This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Neuroscience Mid‑importance This article is within the scope of WikiProject Neuroscience, a collaborative effort to improve the coverage of Neuroscience on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.NeuroscienceWikipedia:WikiProject NeuroscienceTemplate:WikiProject Neuroscienceneuroscience Mid This article has been rated as Mid-importance on the project's importance scale. Molecular Biology: MCB This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology ??? This article has not yet received a rating on the importance scale. This article is supported by the Molecular and Cell Biology task force (assessed as Mid-importance). Pharmacology Low‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology Low This article has been rated as Low-importance on the project's importance scale. Guild of Copy Editors This article was copy edited by Dhtwiki, a member of the Guild of Copy Editors, on March 20, 2015.Guild of Copy EditorsWikipedia:WikiProject Guild of Copy EditorsTemplate:WikiProject Guild of Copy EditorsGuild of Copy Editors

Archives

/Georgia Institute of Technology Introduction to Neuroscience

The section is not sourced very well: only 1 primary reference. Some possible sources to improve it:

• Fisher, M. (2010). "New Approaches to Neuroprotective Drug Development". Stroke. 42 (1 Suppl): S24 – S27. doi:10.1161/STROKEAHA.110.592394. PMID 21164111.
• Savitz, S. I.; Fisher, M. (2007). "Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials". Annals of Neurology. 61 (5): 396–402. doi:10.1002/ana.21127. PMID 17420989.
• Auriel, E.; Bornstein, N. M. (2010). "Neuroprotection in acute ischemic stroke - current status". Journal of Cellular and Molecular Medicine. 14 (9): 2200–2202. doi:10.1111/j.1582-4934.2010.01135.x. PMID 20716132.
• Tuttolomondo, A.; Di Sciacca, R.; Di Raimondo, D.; Arnao, V.; Renda, C.; Pinto, A.; Licata, G. (2009). "Neuron protection as a therapeutic target in acute ischemic stroke". Current topics in medicinal chemistry. 9 (14): 1317–1334. doi:10.2174/156802609789869646. PMID 19849659.
• Ginsberg, M. D. (2008). "Neuroprotection for ischemic stroke: Past, present and future". Neuropharmacology. 55 (3): 363–389. doi:10.1016/j.neuropharm.2007.12.007. PMC 2631228. PMID 18308347.

Any takers? -- (talk) 16:41, 12 December 2013 (UTC)[reply]